etodolac has been researched along with propranolol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Beaulieu, G | 1 |
| Enever, RP; Heit, MC; Smith, DF | 1 |
| Avraham, R; Ben-Eliyahu, S; Benish, M; Glasner, A; Meiboom, H; Rosenne, E; Shemer, S; Zmora, O | 1 |
| Barshack, I; Ben-Eliyahu, S; Benish, M; Benjamin, B; Hazut, O; Hoffman, A; Shaashua, L; Zmora, N; Zmora, O | 1 |
| Ben-Eliyahu, S; Benish, M; Goldfarb, Y; Levi, B; Melamed, R; Sorski, L | 1 |
| Ben-Eliyahu, S; Benish, M; Benjamin, B; Hazut, O; Hoffman, A; Levi, B; Shaashua, L; Sorski, L; Zmora, O | 1 |
| Ben-Eliyahu, S; Lavon, H; Matzner, P; Melamed, R; Rosenne, E; Shaashua, L; Sorski, L | 1 |
| Chavan, R; Naidu, VGM; Shastri, NR; Thipparaboina, R; Thumuri, D | 1 |
| Allweis, T; Barshack, I; Ben-Eliyahu, S; Birnbaum, Y; Cole, S; Haldar, R; Lavon, H; Lyons, YA; Shaashua, L; Sharon, E; Sood, AK; Zmora, O | 1 |
| Bouche, G; Büchler, MW; Diener, MK; Hackert, T; Hüsing, J; Hüttner, FJ; Knebel, P; Mihaljevic, AL; Rooman, I; Strobel, O | 1 |
| Auer, R; Tennakoon, G | 1 |
1 review(s) available for etodolac and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for etodolac and propranolol
| Article | Year |
|---|---|
Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Etodolac; Female; Humans; Ki-67 Antigen; Killer Cells, Natural; Leukocytes, Mononuclear; Middle Aged; Perioperative Period; Propranolol; Receptors, Adrenergic, beta; Signal Transduction; Transcriptome | 2018 |
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.
Topics: Adult; Clinical Trials, Phase II as Topic; Drug Repositioning; Etodolac; Humans; Pancreatectomy; Propranolol; Prospective Studies; Randomized Controlled Trials as Topic | 2020 |
15 other study(ies) available for etodolac and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Etodolac; Heart Rate; Hemodynamics; Indomethacin; Propranolol; Vascular Resistance | 1985 |
Site-specific drug delivery in the dog using flexible fiberoptic endoscopy.
Topics: Animals; Area Under Curve; Dogs; Drug Delivery Systems; Endoscopes, Gastrointestinal; Etodolac; Fiber Optic Technology; Male; Propranolol | 1998 |
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Topics: Adrenergic beta-Antagonists; Amputation, Surgical; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; CD11a Antigen; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Etodolac; Fas Ligand Protein; Female; Interleukin-12; Killer Cells, Natural; Laparotomy; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Poly I-C; Postoperative Complications; Propranolol; Survival Rate | 2010 |
Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.
Topics: Adrenergic beta-Antagonists; Anastomosis, Surgical; Anastomotic Leak; Animals; Colon; Cyclooxygenase 2 Inhibitors; Digestive System Surgical Procedures; Drug Therapy, Combination; Etodolac; Laparotomy; Pressure; Propranolol; Rats; Rats, Inbred F344; Wound Healing | 2010 |
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Topics: Analysis of Variance; Animals; Chemotherapy, Adjuvant; Disease Models, Animal; Etodolac; Female; Immune Tolerance; Immunocompromised Host; Immunotherapy, Active; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Oligodeoxyribonucleotides; Perioperative Care; Postoperative Complications; Propranolol; Random Allocation; Rats; Rats, Inbred F344; Reference Values; Risk Assessment; Sensitivity and Specificity; Stress, Psychological; Tumor Cells, Cultured | 2011 |
The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
Topics: Abdominal Wall; Adrenergic beta-Antagonists; Anastomosis, Surgical; Animals; Colon; Cyclooxygenase 2 Inhibitors; Etodolac; Female; Laparotomy; Male; Postoperative Complications; Propranolol; Rats; Rats, Inbred F344; Skin; Tensile Strength; Weight Loss; Wound Healing | 2011 |
Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
Topics: Adrenergic beta-Agonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Etodolac; Female; Killer Cells, Natural; Laparotomy; Liver Neoplasms; Male; Mice, Inbred BALB C; Minor Surgical Procedures; Propranolol | 2016 |
Fast dissolving drug-drug eutectics with improved compressibility and synergistic effects.
Topics: Acetaminophen; Animals; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Synergism; Etodolac; Humans; Inflammation Mediators; Mice; Powder Diffraction; Propranolol; Solubility; Spectroscopy, Fourier Transform Infrared | 2017 |
"Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.
Topics: Adrenergic beta-Antagonists; Animals; Cyclooxygenase 2 Inhibitors; Etodolac; Mice; Neoplasm, Residual; NF-kappa B; Propranolol | 2023 |